These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33197266)

  • 1. Complications related to elective generator replacement of the subcutaneous implantable defibrillator.
    van der Stuijt W; Quast ABE; Baalman SWE; de Wilde KC; Brouwer TF; Wilde AAM; Knops RE
    Europace; 2021 Mar; 23(3):395-399. PubMed ID: 33197266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.
    de Veld JA; Pepplinkhuizen S; van der Stuijt W; Quast ABE; Olde Nordkamp LRA; Kooiman KM; Wilde AAM; Smeding L; Knops RE
    Europace; 2023 Jul; 25(7):. PubMed ID: 37379530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity.
    Quast ABE; van Dijk VF; Yap SC; Maass AH; Boersma LVA; Theuns DA; Knops RE
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1010-1016. PubMed ID: 29626366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator.
    Rudic B; Tülümen E; Fastenrath F; Akin I; Borggrefe M; Kuschyk J
    Heart Rhythm; 2020 Mar; 17(3):455-459. PubMed ID: 31669771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    Yamazaki K; Ishida Y; Sasaki S; Toyama Y; Nishizaki K; Kinjo T; Itoh T; Kimura M; Sakai S; Shikanai S; Sorimachi Y; Hamaura S; Tomita H
    J Cardiol; 2022 Nov; 80(5):482-486. PubMed ID: 35902323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
    van der Stuijt W; Pepplinkhuizen S; de Veld JA; Quast ABE; van Halm VP; Bijsterveld NR; Olde Nordkamp LRA; Wilde AAM; Smeding L; Knops RE
    Int J Cardiol; 2024 Mar; 398():131639. PubMed ID: 38065323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score.
    Quast ABE; Baalman SWE; Brouwer TF; Smeding L; Wilde AAM; Burke MC; Knops RE
    Heart Rhythm; 2019 Mar; 16(3):403-410. PubMed ID: 30292861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study.
    Francia P; Biffi M; Adduci C; Ottaviano L; Migliore F; De Bonis S; Dello Russo A; De Filippo P; Viani S; Bongiorni MG; Caravati F; Lavalle C; Landolina ME; Pisanò E; Giorgi D; Lovecchio M; Valsecchi S; Diemberger I
    Europace; 2020 Dec; 22(12):1822-1829. PubMed ID: 33118017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.
    Amin AK; Gold MR; Burke MC; Knight BP; Rajjoub MR; Duffy E; Husby M; Stahl WK; Weiss R
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006665. PubMed ID: 30917689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing.
    Quast ABE; Baalman SWE; Betts TR; Boersma LVA; Bonnemeier H; Boveda S; Brouwer TF; Burke MC; Delnoy PPHM; El-Chami M; Kuschyk J; Lambiase P; Marquie C; Miller MA; Smeding L; Wilde AAM; Knops RE
    Am Heart J; 2019 Aug; 214():167-174. PubMed ID: 31220775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.
    Gould PA; Krahn AD;
    JAMA; 2006 Apr; 295(16):1907-11. PubMed ID: 16639049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator.
    Knight BP; Clémenty N; Amin A; Birgersdotter-Green UM; Roukoz H; Holbrook R; Manlucu J
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):230-237. PubMed ID: 38047467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy: A Computer Modeling Study.
    Heist EK; Belalcazar A; Stahl W; Brouwer TF; Knops RE
    JACC Clin Electrophysiol; 2017 Apr; 3(4):405-414. PubMed ID: 29759454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal defibrillation thresholds and the correlation with implant position in subcutaneous implantable-defibrillator patients.
    Quast ABE; Baalman SWE; Van der Stuijt W; Wilde AAM; Knops RE
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2441-2447. PubMed ID: 31512339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of Implantable Cardioverter-Defibrillator Generator Replacement in a Primary Prevention Population-Based Cohort.
    Weng W; Sapp J; Doucette S; MacIntyre C; Gray C; Gardner M; Abdelwahab A; Parkash R
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1180-1189. PubMed ID: 29759503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort.
    Ruwald MH; Ruwald AC; Johansen JB; Gislason G; Nielsen JC; Philbert B; Riahi S; Vinther M; Lindhardt TB
    Europace; 2019 Aug; 21(8):1211-1219. PubMed ID: 31329849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy with implanted cardioverter-defibrillator: Is a replacement of the impulse generator due to battery depletion also necessary without the occurrence of a tachyarrhythmia episode?].
    Dürsch M; Pitschner HF; Schwarz T; Sperzel J; König S; Bahavar H; Klövekorn WP; Neuzner J
    Z Kardiol; 1998 Jan; 87(1):32-7. PubMed ID: 9531698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE; Gleva MJ; Mela T; Chung MK; Uslan DZ; Borge R; Gottipaty V; Shinn T; Dan D; Feldman LA; Seide H; Winston SA; Gallagher JJ; Langberg JJ; Mitchell K; Holcomb R;
    Circulation; 2010 Oct; 122(16):1553-61. PubMed ID: 20921437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
    Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.
    Viani S; Migliore F; Tola G; Pisanò ECL; Russo AD; Luzzi G; Sartori P; Piro A; Rordorf R; Forleo GB; Rago A; Segreti L; Bertaglia E; Biffi M; Lovecchio M; Valsecchi S; Diemberger I; Bongiorni MG
    Heart Rhythm; 2019 Apr; 16(4):564-571. PubMed ID: 30366163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.